T1	Participants 63 109	patients with mild or borderline hypertension:
T2	Participants 593 695	A total of 18 hypertensive and hyperinsulinemic (= 10 U/mL or more) men and women completed the trial.
T3	Participants 1648 1674	patients with hypertension
